XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements Of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 2,827,000 $ 1,312,000
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 2,499,000 2,285,000
Recovery of doubtful accounts (159,000) (48,000)
Deferred taxes 371,000 (297,000)
Foreign currency transaction losses (gains) (155,000) 115,000
Share-based compensation 936,000 895,000
Unrealized loss on available for sale equity security 37,000 0
Realized gain on available for sale market securities (3,000) 0
Changes in operating assets and liabilities:    
Accounts receivable (4,928,000) 171,000
Inventories (2,845,000) (3,163,000)
Other assets (542,000) (31,000)
Accounts payable 4,266,000 (2,100,000)
Advance customer payments 10,000 62,000
Accrued expenses 1,782,000 (1,627,000)
Net cash provided by (used in) operating activities 4,096,000 (2,426,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from maturities of available-for-sale marketable securities 8,053,000 6,931,000
Proceeds from sales of available-for-sale marketable securities 545,000 0
Purchases of available-for-sale marketable securities (8,944,000) (7,475,000)
Additions to equipment and leasehold improvements (1,964,000) (1,226,000)
Additions to patents (115,000) (120,000)
Net cash used in investing activities (2,425,000) (1,890,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of stock options 525,000 378,000
Tax payments related to shares withheld for share-based compensation plans (123,000) (35,000)
Common stock repurchases 0 (240,000)
Proceeds from issuance of common stock under employee stock purchase plan 219,000 258,000
Net cash provided by financing activities 621,000 361,000
Effects of exchange rate changes on cash and cash equivalents 12,000 259,000
Net increase (decrease) in cash and cash equivalents 2,304,000 (3,696,000)
Cash and cash equivalents – beginning of period 6,944,000 10,640,000
Cash and cash equivalents – end of period $ 9,248,000 $ 6,944,000